BIOMX INC's ticker is PHGE and the CUSIP is 09090D103. A total of 17 filers reported holding BIOMX INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,424 | -2.2% | 49,500 | 0.0% | 0.00% | – |
| Q2 2023 | $17,820 | +18.0% | 49,500 | 0.0% | 0.00% | – |
| Q1 2023 | $15,098 | +63.4% | 49,500 | 0.0% | 0.00% | – |
| Q4 2022 | $9,242 | -53.8% | 49,500 | -15.7% | 0.00% | -100.0% |
| Q3 2022 | $20,000 | -53.5% | 58,700 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $43,000 | -61.9% | 58,700 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $113,000 | -28.5% | 58,700 | -40.5% | 0.00% | -33.3% |
| Q4 2021 | $158,000 | -74.3% | 98,700 | -50.8% | 0.00% | -75.0% |
| Q3 2021 | $614,000 | +8.1% | 200,700 | +93.0% | 0.01% | +20.0% |
| Q2 2021 | $568,000 | -35.2% | 104,000 | -15.4% | 0.01% | -37.5% |
| Q1 2021 | $876,000 | – | 123,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 2,133,402 | $11,648,000 | 1.19% |
| MMCAP International Inc. SPC | 684,451 | $3,737,000 | 0.18% |
| Orbimed Advisors | 2,313,489 | $12,632,000 | 0.13% |
| Taylor Wealth Management Partners | 31,804 | $174,000 | 0.06% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 14,207 | $78,000 | 0.04% |
| ROYCE & ASSOCIATES LP | 359,000 | $1,960,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 104,000 | $568,000 | 0.01% |
| J. Goldman & Co LP | 150,000 | $92,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 427,702 | $2,335,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,060 | $6,000 | 0.00% |